These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 9988931)

  • 1. Is it truly random?
    Markey P
    Aust Fam Physician; 1999 Jan; 28 Suppl 1():S48. PubMed ID: 9988931
    [No Abstract]   [Full Text] [Related]  

  • 2. Stimulant dosing in the community treatment of adult attention-deficit/hyperactivity disorder.
    Olfson M; Marcus SC; Zhang HF; Wan GJ
    J Clin Psychopharmacol; 2008 Apr; 28(2):255-7. PubMed ID: 18344749
    [No Abstract]   [Full Text] [Related]  

  • 3. Is the dose in the therapeutic range?
    Kramer J
    Aust Fam Physician; 1999 Jan; 28 Suppl 1():S47. PubMed ID: 9988930
    [No Abstract]   [Full Text] [Related]  

  • 4. Attention deficit hyperactivity disorder in children.
    Ramchandani P; Joughin C; Zwi M
    Clin Evid; 2002 Jun; (7):262-71. PubMed ID: 12230649
    [No Abstract]   [Full Text] [Related]  

  • 5. Comments on efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder.
    Pae CU
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1149-50; author reply 1151-2. PubMed ID: 17493730
    [No Abstract]   [Full Text] [Related]  

  • 6. Flawed attention-deficit/hyperactivity disorder medication comparison.
    Adesman A
    Pediatrics; 2004 Oct; 114(4):1132; author reply 1132-3. PubMed ID: 15466129
    [No Abstract]   [Full Text] [Related]  

  • 7. An n-of-1 trial service in clinical practice: testing the effectiveness of stimulants for attention-deficit/hyperactivity disorder.
    Nikles CJ; Mitchell GK; Del Mar CB; Clavarino A; McNairn N
    Pediatrics; 2006 Jun; 117(6):2040-6. PubMed ID: 16740846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transdermal methylphenidate (Daytrana) for ADHD.
    Med Lett Drugs Ther; 2006 Jun; 48(1237):49-51. PubMed ID: 16785850
    [No Abstract]   [Full Text] [Related]  

  • 9. Response to Calver et al. on the WA regulatory scheme for stimulants.
    Stevens M
    Aust N Z J Public Health; 2008 Apr; 32(2):182. PubMed ID: 18412693
    [No Abstract]   [Full Text] [Related]  

  • 10. Australia: the N of 1 trial, an underappreciated research method.
    Rodnick JE
    Fam Med; 2006 Jan; 38(1):63. PubMed ID: 16378265
    [No Abstract]   [Full Text] [Related]  

  • 11. N of 1 trials. Practical tools for medication management.
    Nikles CJ; Glasziou PP; Del Mar CB; Duggan CM; Mitchell G
    Aust Fam Physician; 2000 Nov; 29(11):1108-12. PubMed ID: 11127076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylphenidate and chromosome damage.
    Jacobson-Kram D; Mattison D; Shelby M; Slikker W; Tice R; Witt K
    Cancer Lett; 2008 Feb; 260(1-2):216-8. PubMed ID: 18055105
    [No Abstract]   [Full Text] [Related]  

  • 13. Seizures caused by concomitant use of lindane and dextroamphetamine in a child with attention deficit hyperactivity disorder.
    Cox R; Krupnick J; Bush N; Houpt A
    J Miss State Med Assoc; 2000 Aug; 41(8):690-2. PubMed ID: 10974795
    [No Abstract]   [Full Text] [Related]  

  • 14. AD(H)D.
    Harrison C; Charles J; Britt H
    Aust Fam Physician; 2008 Jun; 37(6):393. PubMed ID: 18523688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment with central nervous system stimulants].
    Zlotnik G
    Ugeskr Laeger; 2004 Mar; 166(10):925; author reply 925. PubMed ID: 15045741
    [No Abstract]   [Full Text] [Related]  

  • 16. [Central nervous system stimulants in AD/HD in adults].
    Aanonsen NO; Lensing MB; Mathiesen T
    Tidsskr Nor Laegeforen; 1999 Jan; 119(1):82-3. PubMed ID: 10025211
    [No Abstract]   [Full Text] [Related]  

  • 17. Dexmethylphenidate (Focalin) for ADHD.
    Med Lett Drugs Ther; 2002 May; 44(1130):45-6. PubMed ID: 12011757
    [No Abstract]   [Full Text] [Related]  

  • 18. [Central nervous system stimulants in adults with AD/HD].
    Stovner AM; Wyller TB; Skulberg A; Os L; Korsmo G
    Tidsskr Nor Laegeforen; 1999 Jan; 119(3):410. PubMed ID: 10074845
    [No Abstract]   [Full Text] [Related]  

  • 19. [Central nervous system stimulants and their potential risk of abuse in hyperkinetic disorders].
    Aanonsen NO
    Tidsskr Nor Laegeforen; 1999 Nov; 119(27):4040-2. PubMed ID: 10613094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Attention deficit-hyperactivity disorder (ADHD); etiology, diagnosis and treatment].
    't Jong GW; van den Anker JN
    Ned Tijdschr Geneeskd; 2000 Nov; 144(46):2227-8. PubMed ID: 11103263
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.